Evidence map›Paper›PMID 34569871›Full record

Trial reportJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2022

A randomized controlled trial to assess the influence of a picture-based antiemetic medication calendar on medication-taking behavior in adults receiving chemotherapy.

Mira Maximos, Kelly Smith, Venita Harris, Thomas McFarlane, Jonathan Blay, Karin Hahn, Feng Chang

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mira Maximos10033London Regional Cancer Centre & London Health Sciences Centre, London, ON, Canada.ORCID 0000-0001-6385-9718
Kelly Smith10033London Regional Cancer Centre & London Health Sciences Centre, London, ON, Canada.
Venita Harris10033London Regional Cancer Centre & London Health Sciences Centre, London, ON, Canada.
Thomas McFarlane8430University of Waterloo School of Pharmacy, Kitchener, ON, Canada.
Jonathan Blay8430University of Waterloo School of Pharmacy, Kitchener, ON, Canada.
Karin Hahn10033London Regional Cancer Centre & London Health Sciences Centre, London, ON, Canada.
Feng Chang8430University of Waterloo School of Pharmacy, Kitchener, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveA prospective open-label randomized controlled trial to assess the role of a picture-based medication calendar on adherence to antiemetic regimens for adult patients receiving chemotherapy and assess the effect on other medication taking behaviors as well as patient satisfaction with the tool.

methodsParticipants were randomly assigned 1:1 to routine care with or without calendar.

resultsAdherence, stratified by education (university or postgraduate,

conclusionThe picture-based medication calendar did not statistically affect adherence to scheduled antiemetics among outpatients receiving chemotherapy for solid organ tumor origins. However, participants indicated that the calendar was effective for keeping track of medications, had an easy-to-understand layout, and provided help around when and how to take medications related to the oncology regimen.

Indexed as

AntiemeticsNeoplasmsAdultHumansMedication AdherenceProspective StudiesAntiemeticscancerchemotherapycomplex medication regimenPatient adherencepictorial aid

Identifiers

PMID34569871
PMCPMC9623335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.